Ting Yu

发表

Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population

Zhiwei Chen, T. Xie, Jiaying Hou, 2022, Frontiers in Endocrinology.

Mean Corpuscular Hemoglobin Predicts Length of Hospital Stay Independent of Severity Classification in Acute Pancreatitis Patients: a Retrospective Study

Ting Yu, Hao Lin, Rong Xu, 2021 .

Optimum Number of Oocytes Retrieved Among Patients With Polycystic Ovary Syndrome Treated Using The Follicular Phase Long-Acting Long Protocol: A Retrospective Cohort Study

J. Zhai, Di Wu, Ting Yu, 2021 .

Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy

R. Mackey, C. Wassel, J. Gayle, 2021, ClinicoEconomics and outcomes research : CEOR.

Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy.

S. Chandra, R. Kim, H. Phatak, 2020, Future oncology.

Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: A multicentre propensity score matching study

W. Lau, Yi Gong, Zhi-Yu Chen, 2022, Frontiers in Oncology.

High expression of Dll4 and CD44V6 is associated with clinicopathological characteristics and poor prognosis in osteosarcoma patients

Ting Yu, Ye Wang, Haiyang Xie, 2021, Translational cancer research.

Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors

C. Wassel, S. George, J. Gayle, 2021, The Oncologist.

How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.

M. Schlichting, M. Bharmal, V. Kapetanakis, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.